Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Head and Neck Neoplasms 1

Interventions

Gene Expression Profiling 10Immunohistochemistry 9Blood Specimen Collection 8Cisplatin 7Polymerase Chain Reaction 6Cetuximab 6pembrolizumab 5Surveys and Questionnaires 5Radiotherapy 5Nivolumab 4Microarray Analysis 4Immunoenzyme Techniques 3Flow Cytometry 3Biopsy 3Tissue Banks 2Therapeutics 2Reverse Transcriptase Polymerase Chain Reaction 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2Mass Spectrometry 2Liquid Biopsy 2Immunologic Techniques 2Drug Therapy 2Chemotherapy, Adjuvant 2Amplified Fragment Length Polymorphism Analysis 2durvalumab 1X-Ray Therapy 1Tomography, X-Ray Computed 1Tomography, Optical Coherence 1Tissue Array Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Squamous Cell Carcinoma of Head and Neck × Tissue Array Analysis × Clear all
NCT00898742 2013-04-02

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Vanderbilt-Ingram Cancer Center

Terminated
58 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡